Treatment of Attention Deficit-Hyperactivity Disorder in a Pediatric Patient with COVID-19
Abstract
It is unknown that the novel Coronavirus (COVID-19), which emerged for the first time in December 2019 and spread all over the world, have affected how
many children symptomatically or asymptomatically. The uncertainty of the treatment algorithm of pandemic factor and rapidly developing pandemic process
created a chaotic environment in whole world. Children and adolescents have been adversely affected by this chaotic environment. Studies examining
the effects of this period on the mental health of children and adolescents are scarce. It has been suggested that individuals with psychiatric disorders such as
attention deficit-hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) adapted more difficultly and were affected more negatively than other
individuals. In this study, we present a patient with ADHD and oppositional defiant disorder (ODD) who was using short-acting methylphenidate (IRISMPH)
for treatment, had no worsening or any adverse side effects and was treated carefully for COVID-19 infection. However, further studies are required
to evaluate the safety of IRIS-MPH and other psychotropic agents in patients with COVID-19.
Keywords
COVID 19, Attention deficit-hyperactivity disorder, Methylphenidate, Risperidone, Treatment, Child
Supporting Institution
yok
Project Number
yok
Thanks
Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi®
Dear Editor,
Please find enclosed our manuscript entitled “Treatment of Attention Deficit - Hyperactivity Disorder in a Pediatric Patient with COVID 19” by Arıcı Gürbüz et al., for consideration of publication in “Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi ®” as an original article.By submitting the manuscript to “Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi ®”, the authors understand that the material presented in this paper has not been published before nor has been submitted for publication to another scientific journal or being consideration for publication elsewhere. The results presented in this paper have not been published previously in whole or part. I attest that this work has been read and approved by all authors. Also, the authors understand that, subject to acceptance, they will transfer copyright to the Publisher.
Yours sincerely,
Specialist Asiye ARICI GÜRBÜZ
Department of Child and Adolescent Psychiatry ,
Dr. Ekrem Tok Mental Health Diseases and Hospital, Adana, Turkey
E-mail: asiyearici@hotmail.com
Phone: +903443003374 Fax: +903443003409
References
- Golberstein E, Wen H, Miller BF. Coronavirus disease 2019 (COVID-19) and mental health for children and adolescents. JAMA pediatrics. 2020;174(9):819-820.
- T.C. Sağlık Bakanlığı. COVID-19 bilgilendirme platformu. Erişim adresi (22.03. 2021): https://covid19. saglik. gov. tr/TR-66935/genelkoronavirus-tablosu. html.
- Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q et al. A Case Series of children with 2019 novel coronavirus infection: Clinical and epidemiological features. Clinical Infectious Diseases. 2020;71(6):1547-1551.
- Şeker M, Özer A, Tosun Z, Korkut C, Doğrul M. Covid-19 pandemi değerlendirme raporu. Türkiye Bilimler Akademisi. 2020.
- Parıldar H, Dikici MF. Pandemiler tarihi. Klinik Tıp Aile Hekimliği. 2020;12(1):1-8.
- Liu JJ, Bao Y, Huang X, Shi J, Mental health considerations for children quarantined because of COVID-19. The Lancet Child & Adolescent Health. 2020;4(5):347-349.
- Kılınçel Ş, Kılınçel O, Muratdağı G, Aydın A, Usta MB. Factors affecting the anxiety levels of adolescents in home‐quarantine during COVID‐19 pandemic in Turkey. Asia‐Pacific Psychiatry. 2020;13(2):e12406.
- Becker SP, Gregory AM. Editorial Perspective: Perils and promise for child and adolescent sleep and associated psychopathology during the COVID‐19 pandemic. Journal of Child Psychology and Psychiatry. 2020;61(7):757-759.
- Jefsen OH, Rohde C, Nørremark B, Østergaard SD. Editorial Perspective: COVID‐19 pandemic‐related psychopathology in children and adolescents with mental illness. Journal of child psychology and psychiatry. 2020;62(6):798-800.
- Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528.